Trial
NCT04085393
Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alabama at Birmingham
Collaborators
Heron Therapeutics
Condition
Chemotherapy-induced Nausea and Vomiting
Intervention
GRANISETRON EXTENDED RELEASE INJECTION (GERSC)
Why stopped
sponsor withdrew study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-30